---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-186327"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2022-06-30T23:59:59+00:00"
generated_at: "2026-06-24T22:15:03.024766+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ResMed enters amended $1.5B revolver and $200M term loan, both maturing June 2027

## Summary
- Revolver reduced from $1.6B to $1.5B; includes uncommitted $1B increase option.
- New $200M term loan from ResMed Pty subsidiary; amortizes $5M semi-annually.
- Both facilities mature June 29, 2027; interest at SOFR+0.75%-1.50% or Base Rate+0.0%-0.50%.
- Proceeds for general corporate purposes; financial covenant maintains max leverage ratio.
- Obligations guaranteed by specified U.S. subsidiaries including Brightree and MatrixCare.

## SEC filing metadata
- accession: 0001193125-22-186327
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2022-06-30T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312522186327/0001193125-22-186327-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312522186327/d363805d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-186327
- JSON: https://secwatch.observer/filing/0001193125-22-186327.json
- Plain text: https://secwatch.observer/filing/0001193125-22-186327.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.